Australia markets open in 13 minutes

Exopharm Limited (EX1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.01100.0000 (0.00%)
At close: 10:10AM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
618.568
618.568
99.73
-
-
Gross profit
618.568
618.568
99.73
-
-
Operating expenses
Research development
1,732
1,732
2,535
3,166
2,619
Selling general and administrative
6,500
6,500
9,679
8,230
4,792
Total operating expenses
10,210
10,210
14,212
12,667
8,005
Operating income or loss
-9,592
-9,592
-14,113
-12,667
-8,005
Interest expense
331.225
331.225
81.225
-
-
Total other income/expenses net
2,775
2,775
4,107
4,192
2,665
Income before tax
-7,130
-7,130
-10,084
-8,468
-5,279
Income tax expense
0
0
0
0
0
Income from continuing operations
-7,130
-7,130
-10,084
-8,468
-5,279
Net income
-7,130
-7,130
-10,084
-8,468
-5,279
Net income available to common shareholders
-7,130
-7,130
-10,084
-8,468
-5,279
Basic EPS
-0.04
-0.04
-0.06
-0.06
-0.05
Diluted EPS
-0.04
-0.04
-0.06
-0.06
-0.05
Basic average shares
177,717
196,894
177,696
147,634
106,267
Diluted average shares
177,717
196,894
177,696
147,634
106,267